Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/19/2025

Management of Chemotherapy-Induced Diarrhea

Initial Assessment and Exclusion of Infection

  • The American Society of Clinical Oncology recommends ruling out infectious causes, particularly Clostridium difficile, in patients who have received antibiotics, as this occurs in 7-50% of antibiotic-associated diarrhea cases 2
  • Obtain stool testing for C. difficile toxin, blood, fecal leukocytes, and other infectious agents, and check electrolyte profile and complete blood count to assess dehydration status and neutropenia 3
  • Warning signs requiring immediate escalation include fever, dehydration, neutropenia, blood in stool, or dizziness upon standing, indicating complicated cases requiring aggressive intervention 1

First-Line Pharmacologic Management

  • The European Society for Medical Oncology recommends loperamide as the first-line agent for mild to moderate diarrhea, with strong evidence (Grade A-II) 2, 4
  • Start with loperamide 4 mg initial dose, then 2 mg every 4 hours or after each unformed stool, with a maximum of 16 mg/day 1
  • Continue loperamide until 12 hours after diarrhea resolves, and consider increasing to 2 mg every 2 hours if diarrhea persists beyond 24 hours 1, 5

Second-Line Management for Refractory Diarrhea

  • The American Society of Clinical Oncology recommends switching to octreotide if diarrhea persists beyond 48 hours on loperamide, starting with 100-150 μg subcutaneously three times daily 1, 2, 4, 5
  • For severe dehydration, use IV octreotide 25-50 μg/hour by continuous infusion, and titrate upward to 500 μg three times daily if no response to initial dosing 1, 2, 4

Alternative and Adjunctive Therapies

  • The European Society for Medical Oncology suggests considering psyllium seeds, diphenoxylate plus atropine, paregoric tincture of opium, codeine, or morphine as alternatives for severe, persistent cases, with Grade B-III evidence 2, 4
  • Bile acid sequestrants, such as cholestyramine, colestipol, or colesevelam, should be added for suspected bile salt malabsorption 1, 5

Special Considerations by Chemotherapy Agent

  • For irinotecan-induced late-onset diarrhea, treat with loperamide plus budesonide 3 mg three times daily until resolution, or acetorphan 100 mg three times daily for 48 hours 2, 4
  • For immunotherapy-induced diarrhea, use loperamide for grade 1, and add budesonide 9 mg once daily for grade 2 1

Supportive Care Measures

  • Eliminate lactose-containing products, alcohol, spicy foods, coffee, and high-osmolar dietary supplements, and encourage 8-10 large glasses of clear liquids daily to prevent dehydration 1, 5
  • Administer IV fluids targeting urine output >0.5 mL/kg/hour if dehydration is severe, and gradually reintroduce solid foods as symptoms improve 1, 5

Monitoring and Follow-Up

  • Patients must record the number of stools and immediately report fever or dizziness upon standing, and monitor electrolyte balance and hydration status daily in severe cases 1, 3